Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 3,084	$ 21,200
TOTAL ASSETS	3,084	21,200
CURRENT LIABILITIES
Accounts payable and accrued expenses	1,910	810
Related party note and interest payable	84,254	82,411
TOTAL LIABILITIES	86,164	83,221
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $.01 par value; authorized - 5,000,000 shares; issued - none		0
Common stock, $.001 par value; authorized - 30,000,000 shares; issued and outstanding - 2,860,773 on March 31, 2023 and December 31, 2022	2,861	2,861
Additional paid in capital	1,914,819	1,914,819
Accumulated deficit	(2,000,760)	(1,979,701)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	(83,080)	(62,021)
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)	$ 3,084	$ 21,200